Does RISANKIZUMAB-RZAA Cause Symptom recurrence? 33 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Symptom recurrence have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
33
Reports of Symptom recurrence with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
6
Hospitalizations
How Dangerous Is Symptom recurrence From RISANKIZUMAB-RZAA?
Of the 33 reports, 6 (18.2%) required hospitalization.
Is Symptom recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Symptom recurrence?
NIRMATRELVIR\RITONAVIR (990)
DUPILUMAB (399)
SECUKINUMAB (367)
RAVULIZUMAB-CWVZ (221)
EFGARTIGIMOD ALFA-FCAB (163)
ADALIMUMAB (162)
OMALIZUMAB (129)
ECULIZUMAB (128)
TEPROTUMUMAB-TRBW (118)
ARIPIPRAZOLE (115)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Symptom recurrence Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA